Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Briacell Therapeutics Corp
BCTXW
Primary Symbol:
T.BCT
Alternate Symbol(s):
BCTX
Healthcare
Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted...
immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:BCT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Comment by
LondonInvest
on Jul 06, 2022 11:05am
RE:RE:RE:BCTX To Quickly Regain $8/share
I agree, but the 200-DMA is only a slight decline and I like how BCTX is tugging on the 50-DMA pulling it back up. Chart looks like it has a ton of potential on weekly chart. Could have
...more
(54)
•••
dragshot
X
View Profile
View Bullboard History
Comment by
dragshot
on Jul 01, 2022 7:32am
RE:RE:BCTX To Quickly Regain $8/share
I think you're on the right track here with the 50 and 200DMA. We now have a situation with both a falling 50 and 200. This is a red flag for me. I would have sold back in April
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(1)
•••
theleak
X
View Profile
View Bullboard History
Post by
theleak
on May 18, 2022 12:27pm
$NIRV looking good
check out the newly listed $NIRV, sheldon also involved with his son, looks like a big winner in the making! https://ceo.ca/@newsfile/nirvana-signs-letter-of-intent-with-innovate-phytotechnologies
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Comment by
LondonInvest
on May 12, 2022 2:52pm
RE:BCTX To Quickly Regain $8/share
Well, that did not turn out at all how I imagined it. I was able to add at these low levels today. Still think there is really good returns possible here. I am a holder of company
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Apr 29, 2022 5:52am
BCTX To Quickly Regain $8/share
Short-tem, BCTX should quickly regain $8/share to keep the 50-DMA rising and above the 200-DMA. Very bullish here. Short-term this will add confidence the recent decline has put in another
...more
(3)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Apr 14, 2022 8:42am
RE:BCTX Fast Track FDA Approval
Sell off on great news after a run-up on no news!? What's going on? -TIA
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Apr 13, 2022 8:12am
BCTX Fast Track FDA Approval
Well this week's options trading isn't at all suspicious! I am long so happy about great advancement for company on outstanding news, but someone definitely leaked something for all
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Apr 12, 2022 1:31pm
Not Puts Being Exercised
Today's action in BCTX is being postulated as PUTS being exercise, but this does not explain the massive purchasing of CALLS all day. Now it is 12,512 contracts for April 14, 2022 Strike $12
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Apr 12, 2022 1:27pm
1.1M Options Shares Bought 2 Days Left
Today, BCTX prior to its poster presentation this afternoon has had volatile trading moving around 20% with over 3 million shares traded. More interesting, there have been 11,000 contracts for
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Mar 25, 2022 7:39am
Potential for this company - 10x ($100+/share)
I have bought BCTX aggressively because it is a very undervalued company for it's potential value in its research. I have been trying to calculate what potential value is if their tech
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Mar 22, 2022 3:54pm
Massive Short Squeeze Possible Above $10.50
Facts: Currently about 15% of the outstandind shares of BCTX are shorted. Taking into account the tightly held shares by institutions and insider holdings the short position is closer to 40% of float
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Mar 22, 2022 10:20am
Likely Trend Up For Break Away Gap
This is just speculation, but the chart action in BCTX is very encouraging going into the AACR on April 12, 2022. I expect it to continue to rise into the $10-$11 range and build a higher base.&
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Mar 17, 2022 3:40pm
Keytruda Lung Cancer Reduction, Good News for BCTX Study
Merck just released results for their Keytruda Lung cancer study and it showed a 24% reduction in disease recurrence or death. Good news for Briacell as this is one of the new therapeutic
...more
(47)
•••
LondonInvest
X
View Profile
View Bullboard History
Post by
LondonInvest
on Mar 17, 2022 9:36am
No gaps in chart, short interest still high, Lassonde Curve
From a technical perspective it is nice to see BCTX trading in ranges everyday to keep chart tight and clean. I am not a fan of gap ups as they are filled usually. A breakaway gap on an
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >